- Home
- DVA vs COKE Comparison
DVA vs COKE Comparison
Compare DVA & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- COKE
- Stock Information
- Founded
- DVA 1994
- COKE 1902
- Country
- DVA United States
- COKE United States
- Employees
- DVA N/A
- COKE N/A
- Industry
- DVA Misc Health and Biotechnology Services
- COKE Beverages (Production/Distribution)
- Sector
- DVA Health Care
- COKE Consumer Staples
- Exchange
- DVA Nasdaq
- COKE Nasdaq
- Market Cap
- DVA 9.7B
- COKE 10.2B
- IPO Year
- DVA 1995
- COKE N/A
- Fundamental
- Price
- DVA $137.82
- COKE $120.81
- Analyst Decision
- DVA Hold
- COKE
- Analyst Count
- DVA 2
- COKE 0
- Target Price
- DVA $162.00
- COKE N/A
- AVG Volume (30 Days)
- DVA 701.0K
- COKE 386.8K
- Earning Date
- DVA 10-28-2025
- COKE 10-29-2025
- Dividend Yield
- DVA N/A
- COKE 0.83%
- EPS Growth
- DVA 8.72
- COKE 24.05
- EPS
- DVA 10.20
- COKE 6.71
- Revenue
- DVA $13,161,328,000.00
- COKE $6,947,643,000.00
- Revenue This Year
- DVA $5.96
- COKE N/A
- Revenue Next Year
- DVA $3.54
- COKE N/A
- P/E Ratio
- DVA $13.47
- COKE $17.79
- Revenue Growth
- DVA 5.09
- COKE 3.22
- 52 Week Low
- DVA $126.07
- COKE $105.21
- 52 Week High
- DVA $179.60
- COKE $146.09
- Technical
- Relative Strength Index (RSI)
- DVA 51.25
- COKE 62.58
- Support Level
- DVA $135.04
- COKE $115.41
- Resistance Level
- DVA $137.29
- COKE $117.80
- Average True Range (ATR)
- DVA 2.88
- COKE 2.23
- MACD
- DVA 0.26
- COKE 0.25
- Stochastic Oscillator
- DVA 54.32
- COKE 92.80
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.